Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55


The acute effects of dietary carbohydrate reduction on postprandial responses of non-esterified fatty acids and triglycerides: a randomized trial.

Samkani A, Skytte MJ, Anholm C, Astrup A, Deacon CF, Holst JJ, Madsbad S, Boston R, Krarup T, Haugaard SB.

Lipids Health Dis. 2018 Dec 27;17(1):295. doi: 10.1186/s12944-018-0953-8.


Acute Effects of Dietary Carbohydrate Restriction on Glycemia, Lipemia and Appetite Regulating Hormones in Normal-Weight to Obese Subjects.

Samkani A, Skytte MJ, Thomsen MN, Astrup A, Deacon CF, Holst JJ, Madsbad S, Rehfeld JF, Krarup T, Haugaard SB.

Nutrients. 2018 Sep 12;10(9). pii: E1285. doi: 10.3390/nu10091285.


A carbohydrate-reduced high-protein diet acutely decreases postprandial and diurnal glucose excursions in type 2 diabetes patients.

Samkani A, Skytte MJ, Kandel D, Kjaer S, Astrup A, Deacon CF, Holst JJ, Madsbad S, Rehfeld JF, Haugaard SB, Krarup T.

Br J Nutr. 2018 Apr;119(8):910-917. doi: 10.1017/S0007114518000521.


Effects of the glucagon-like peptide-1 receptor agonist liraglutide on 24-h ambulatory blood pressure in patients with type 2 diabetes and stable coronary artery disease: a randomized, double-blind, placebo-controlled, crossover study.

Kumarathurai P, Anholm C, Fabricius-Bjerre A, Nielsen OW, Kristiansen O, Madsbad S, Haugaard SB, Sajadieh A.

J Hypertens. 2017 May;35(5):1070-1078. doi: 10.1097/HJH.0000000000001275.


Liraglutide effects on beta-cell, insulin sensitivity and glucose effectiveness in patients with stable coronary artery disease and newly diagnosed type 2 diabetes.

Anholm C, Kumarathurai P, Pedersen LR, Nielsen OW, Kristiansen OP, Fenger M, Madsbad S, Sajadieh A, Haugaard SB.

Diabetes Obes Metab. 2017 Jun;19(6):850-857. doi: 10.1111/dom.12891. Epub 2017 Feb 23.


Effects of Liraglutide on Heart Rate and Heart Rate Variability: A Randomized, Double-Blind, Placebo-Controlled Crossover Study.

Kumarathurai P, Anholm C, Larsen BS, Olsen RH, Madsbad S, Kristiansen O, Nielsen OW, Haugaard SB, Sajadieh A.

Diabetes Care. 2017 Jan;40(1):117-124. doi: 10.2337/dc16-1580. Epub 2016 Oct 19.


Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study.

Kumarathurai P, Anholm C, Nielsen OW, Kristiansen OP, Mølvig J, Madsbad S, Haugaard SB, Sajadieh A.

Cardiovasc Diabetol. 2016 Jul 26;15(1):105. doi: 10.1186/s12933-016-0425-2.


Coronary flow velocity reserve by echocardiography: feasibility, reproducibility and agreement with PET in overweight and obese patients with stable and revascularized coronary artery disease.

Olsen RH, Pedersen LR, Snoer M, Christensen TE, Ghotbi AA, Hasbak P, Kjaer A, Haugaard SB, Prescott E.

Cardiovasc Ultrasound. 2016 Jun 7;14(1):22. doi: 10.1186/s12947-016-0066-3.


T-lymphocyte subset dynamics in well-treated HIV-infected men during a bout of exhausting exercise.

Dirksen C, Hansen BR, Kolte L, Haugaard SB, Andersen O.

Infect Dis (Lond). 2015;47(12):919-23. Epub 2015 Aug 5.


A randomised trial comparing the effect of exercise training and weight loss on microvascular function in coronary artery disease.

Olsen RH, Pedersen LR, Jürs A, Snoer M, Haugaard SB, Prescott E.

Int J Cardiol. 2015 Apr 15;185:229-35. doi: 10.1016/j.ijcard.2015.03.118. Epub 2015 Mar 11.


Alteration in pancreatic islet function in human immunodeficiency virus.

Haugaard SB.

Endocrinol Metab Clin North Am. 2014 Sep;43(3):697-708. doi: 10.1016/j.ecl.2014.06.004. Review.


A randomised trial comparing weight loss with aerobic exercise in overweight individuals with coronary artery disease: The CUT-IT trial.

Pedersen LR, Olsen RH, Jürs A, Astrup A, Chabanova E, Simonsen L, Wisløff U, Haugaard SB, Prescott E.

Eur J Prev Cardiol. 2015 Aug;22(8):1009-17. doi: 10.1177/2047487314545280. Epub 2014 Jul 31.


Adding liraglutide to the backbone therapy of biguanide in patients with coronary artery disease and newly diagnosed type-2 diabetes (the AddHope2 study): a randomised controlled study protocol.

Anholm C, Kumarathurai P, Klit MS, Kristiansen OP, Nielsen OW, Ladelund S, Madsbad S, Sajadieh A, Haugaard SB; AddHope2 Trial Study Group.

BMJ Open. 2014 Jul 16;4(7):e005942. doi: 10.1136/bmjopen-2014-005942.


Coronary flow reserve predicts cardiopulmonary fitness in patients with coronary artery disease independently of systolic and diastolic function.

Snoer M, Olsen RH, Monk-Hansen T, Pedersen LR, Haugaard SB, Dela F, Prescott E.

Echocardiography. 2014 May;31(5):654-62. doi: 10.1111/echo.12445. Epub 2013 Dec 3.


Soluble urokinase plasminogen activator receptor, C-reactive protein and triglyceride are associated with heart rate variability in non-diabetic Danes.

Intzilakis T, Hartmann G, Mouridsen MR, Eugen-Olsen J, Kumarathurai P, Madsbad S, Almdal TP, Haugaard SB, Sajadieh A.

Eur J Clin Invest. 2013 May;43(5):457-68. doi: 10.1111/eci.12070. Epub 2013 Mar 20.


Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score.

Lyngbæk S, Marott JL, Sehestedt T, Hansen TW, Olsen MH, Andersen O, Linneberg A, Haugaard SB, Eugen-Olsen J, Hansen PR, Jeppesen J.

Int J Cardiol. 2013 Sep 10;167(6):2904-11. doi: 10.1016/j.ijcard.2012.07.018. Epub 2012 Aug 19.


The effect of a very low calorie diet on insulin sensitivity, beta cell function, insulin clearance, incretin hormone secretion, androgen levels and body composition in obese young women.

Svendsen PF, Jensen FK, Holst JJ, Haugaard SB, Nilas L, Madsbad S.

Scand J Clin Lab Invest. 2012 Sep;72(5):410-9. doi: 10.3109/00365513.2012.691542. Epub 2012 Jun 18.


Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ T lymphocytes in HIV-1-infected males.

Bang U, Kolte L, Hitz M, Dam Nielsen S, Schierbeck LL, Andersen O, Haugaard SB, Mathiesen L, Benfield T, Jensen JE.

HIV Clin Trials. 2012 May-Jun;13(3):162-70. doi: 10.1310/hct1303-162.


CRP and suPAR are differently related to anthropometry and subclinical organ damage.

Lyngbæk S, Sehestedt T, Marott JL, Hansen TW, Olsen MH, Andersen O, Linneberg A, Madsbad S, Haugaard SB, Eugen-Olsen J, Jeppesen J.

Int J Cardiol. 2013 Aug 10;167(3):781-5. doi: 10.1016/j.ijcard.2012.03.040. Epub 2012 Mar 28.


Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women.

Bendsen NT, Stender S, Szecsi PB, Pedersen SB, Basu S, Hellgren LI, Newman JW, Larsen TM, Haugaard SB, Astrup A.

J Lipid Res. 2011 Oct;52(10):1821-8. doi: 10.1194/jlr.M014738. Epub 2011 Jul 27.

Supplemental Content

Loading ...
Support Center